Cargando…

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.

Detalles Bibliográficos
Autores principales:	Lissoni, P., Barni, S., Rescaldani, R., Rovelli, F., Tancini, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247096/ https://www.ncbi.nlm.nih.gov/pubmed/2803934

Ejemplares similares

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
por: Lissoni, P., et al.
Publicado: (1994)

Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
por: Lissoni, P., et al.
Publicado: (1990)

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
por: Lissoni, P., et al.
Publicado: (1992)

A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
por: Lissoni, P., et al.
Publicado: (1996)

Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
por: Lissoni, P., et al.
Publicado: (1991)

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
por: Fumagalli, L, et al.
Publicado: (1999)

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993)

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.
por: Lissoni, P., et al.
Publicado: (1995)

Evidence for altered opioid activity in patients with cancer.
por: Lissoni, P., et al.
Publicado: (1987)

Serum Levels of Soluble Interleukin-2 Receptor in Pulmonary Tuberculosis
por: Choi, Soo Jeon, et al.
Publicado: (1990)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma
por: Sobjanek, Michal, et al.
Publicado: (2016)

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
por: Marino, P., et al.
Publicado: (1990)

Effects of Beryllium on Human Serum Immunoglobulin and Lymphocyte Subpopulation
por: Kim, Ki-Woong, et al.
Publicado: (2013)

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
por: Pizzolo, G., et al.
Publicado: (1987)

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2012)

Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation.
por: Siemann, D. W., et al.
Publicado: (1981)

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.
por: Miles, D. W., et al.
Publicado: (1992)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
por: Nakata, B., et al.
Publicado: (1998)

The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis
por: Chen, Xiaohong, et al.
Publicado: (2020)

Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL
por: MITOBE, Yuta, et al.
Publicado: (2023)

Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.
por: Eremin, O., et al.
Publicado: (1980)

Regulation of intracellular pH in subpopulations of cells derived from spheroids and solid tumours.
por: Boyer, M. J., et al.
Publicado: (1993)

Expression of Growth Hormone Receptors by Lymphocyte subpopulations in the Human tonsil
por: Thellin, Olivier, et al.
Publicado: (1998)

Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis
por: Kobayashi, Yuta, et al.
Publicado: (2021)

Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype
por: He, Yi, et al.
Publicado: (2022)

Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study
por: Kohsari, Maryam, et al.
Publicado: (2020)

Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma
por: Suzuki, Kayo, et al.
Publicado: (2022)

Localized interleukin-12 delivery for immunotherapy of solid tumours
por: Wei, Louis Z, et al.
Publicado: (2013)

Determination of cell-free interleukin 2 receptor level in the serum of normal animals and of animals bearing IL-2 receptor positive tumours with high or low metastatic capacity.
por: Schirrmacher, V., et al.
Publicado: (1987)

Elevation of soluble interleukin-2 receptor levels in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

The Fc receptor on thymus-derived lymphocytes. I. Detection of a subpopulation of murine T lymphocytes bearing the Fc receptor
Publicado: (1975)

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010)

Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis
por: Miyata, Jun, et al.
Publicado: (2020)

Serum soluble interleukin-2 receptor levels for screening for malignant lymphomas and differential diagnosis from other conditions
por: Murakami, Jun, et al.
Publicado: (2019)

Soluble interleukin-2 receptors in ulcerative colitis
por: Nielsen, O. H., et al.
Publicado: (1993)

Lymphocyte Subpopulation Number and Function in Infancy
por: Stern, Debra A., et al.
Publicado: (1992)

Autologous stimulation of human lymphocyte subpopulation
Publicado: (1975)

Gangliosides as markers for murine lymphocyte subpopulations
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_tlb89mqr2t44bequigh873hlh9